Currently out of the existing stock ratings of Alex Arfaei, 34 are a HOLD (33.66%), 53 are a BUY (52.48%), 14 are a SELL (13.86%).

Alex Arfaei

Work Performance Price Targets & Ratings Chart

Analyst Alex Arfaei, currently employed carries an average stock price target met ratio of 100% that have a potential upside of 35.93% achieved within 540 days. Previously, Alex Arfaei worked at BMO.

Alex Arfaei’s has documented 186 price targets and ratings displayed on 8 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on ZTS, Zoetis at 09-May-2019.

Wall Street Analyst Alex Arfaei

Analyst best performing recommendations are on ABBV (ABBVIE).
The best stock recommendation documented was for ABBV (ABBVIE) at 5/23/2018. The price target of $78 was fulfilled within 2 days with a profit of $2.36 (2.94%) receiving and performance score of 14.68.

Average potential price target upside

of $20.03 (45.22%) on MRK (MERCK MPANY).
of $18.54 (38.58%) on ABBV (ABBVIE).
of $14.97 (19.56%) on LLY (ELI LILLY AND COMPANY).

ABBV AbbVie BMY Bristol-Myers Squibb Company LLY Eli Lilly and Company MRK Merck mpany PFE Pfizer AZN AstraZeneca PLC ADR KIN Kindred Biosciences ZTS Zoetis

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Gregg Gilbert (BAML)